Cytovia Therapeutics
Dr. Armin Rath is an accomplished leader in the biopharmaceutical industry with extensive experience spanning over two decades. Currently serving as the Senior Vice President and Head of New Product Development & Research Alliances at Cytovia Therapeutics since October 2019, Dr. Rath has held multiple key positions within the company, including VP for GPC3 Franchise Lead Solid Tumors and VP of Business Development. As the founder and managing director of ARA-Health GmbH since May 2017, Dr. Rath has also co-founded HomeDok and served as its Managing Director until September 2022. Previous roles include Regional Vice President at Vector Therapeutics, Managing Director at Shionogi Inc., General Manager at Archimedes Pharma Germany, and various positions in sales, marketing, and pricing at Baxter, Pfizer, and Pharmacia & Upjohn. Dr. Rath began academic pursuits as a scientific assistant at Albert-Ludwigs-Universität Freiburg im Breisgau, focusing on hematology and oncology research.
This person is not in any teams
This person is not in any offices
Cytovia Therapeutics
2 followers
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.